• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

谷氨酸能系统在强迫症中的作用及其可能的治疗意义。

Role of Glutamatergic System in Obsessive-Compulsive Disorder with Possible Therapeutic Implications.

机构信息

National Institute of Mental Health, Topolová 748, 250 67 Klecany, Czech Republic.

Third Faculty of Medicine, Charles University, Ruská 87, 100 00 Prague 10, Czech Republic.

出版信息

Pharmacopsychiatry. 2018 Nov;51(6):229-242. doi: 10.1055/s-0043-118665. Epub 2017 Sep 26.

DOI:10.1055/s-0043-118665
PMID:28950396
Abstract

Obsessive-compulsive disorder (OCD) is a chronic psychiatric illness and 1 of the most common anxiety disorders with the prevalence of 3%. Although its pathogenesis remains unclear, the traditional model focused on alternations in the serotonin system. Selective serotonin reuptake inhibitors provide the most effective treatment; however, as much as 40-60% of patients do not respond to antidepressants therapy. Thus, attention has shifted towards other neurotransmitter systems and related neuroanatomical structures. Recently, there is extensive evidence showing a key role of glutamate pathways abnormalities within the cortico-striatal-thalamo-cortical circuitry and temporal lobes in OCD pathogenesis. In this review, we link together the existent neuroanatomical, neurophysiological, and neuropsychological evidence to argue for potential benefits of adjuvant treatment with glutamatergic agents, especially memantine. By a targeted de-excitation effect on the glutamatergic system in the temporal lobes and connected brain regions, memantine might further alleviate OCD symptoms. This effect should be even more pronounced in certain subtypes of patients with specific cognitive deficits and maladaptive compensatory memory processes (e.g., checkers).

摘要

强迫症(OCD)是一种慢性精神疾病,也是最常见的焦虑症之一,其患病率为 3%。尽管其发病机制仍不清楚,但传统模式侧重于 5-羟色胺系统的改变。选择性 5-羟色胺再摄取抑制剂提供了最有效的治疗方法;然而,多达 40-60%的患者对抗抑郁药治疗没有反应。因此,人们的注意力已经转向其他神经递质系统和相关的神经解剖结构。最近,有大量证据表明,谷氨酸能通路异常在皮质-纹状体-丘脑-皮质回路和颞叶中的作用在 OCD 的发病机制中起着关键作用。在这篇综述中,我们将现有的神经解剖学、神经生理学和神经心理学证据联系起来,以证明辅助使用谷氨酸能药物(特别是美金刚)治疗的潜在益处。通过对颞叶和相关脑区的谷氨酸能系统进行靶向去兴奋作用,美金刚可能会进一步减轻 OCD 症状。对于具有特定认知缺陷和适应不良补偿性记忆过程(例如,检查者)的某些特定亚型患者,这种效果应该更为明显。

相似文献

1
Role of Glutamatergic System in Obsessive-Compulsive Disorder with Possible Therapeutic Implications.谷氨酸能系统在强迫症中的作用及其可能的治疗意义。
Pharmacopsychiatry. 2018 Nov;51(6):229-242. doi: 10.1055/s-0043-118665. Epub 2017 Sep 26.
2
Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trial.谷氨酸能药物治疗强迫症(OCD)和自闭症谱系障碍(ASD)——一项随机对照试验的研究方案
Trials. 2016 Mar 17;17(1):141. doi: 10.1186/s13063-016-1266-8.
3
Glutamate-Modulating Drugs as a Potential Therapeutic Strategy in Obsessive-Compulsive Disorder.谷氨酸调节药物作为强迫症的一种潜在治疗策略。
Curr Neuropharmacol. 2017;15(7):977-995. doi: 10.2174/1570159X15666170320104237.
4
[Significance of the glutaminergic system for obsessive-compulsive disorder].[谷氨酰胺能系统在强迫症中的意义]
Ugeskr Laeger. 2008 Sep 8;170(37):2874-6.
5
New horizons for obsessive-compulsive disorder drug discovery: is targeting glutamate receptors the answer?强迫症药物研发的新视野:靶向谷氨酸受体是答案吗?
Expert Opin Drug Discov. 2024 Oct;19(10):1235-1245. doi: 10.1080/17460441.2024.2387127. Epub 2024 Aug 6.
6
Obsessive compulsive disorder and the glutamatergic system.强迫症与谷氨酸能系统。
Curr Opin Psychiatry. 2014 Jan;27(1):32-7. doi: 10.1097/YCO.0000000000000017.
7
Glutamatergic Agents in the Treatment of Compulsivity and Impulsivity in Child and Adolescent Psychiatry: a Systematic Review of the Literature.谷氨酸能药物治疗儿童和青少年精神病学中的强迫和冲动行为:文献系统综述
Z Kinder Jugendpsychiatr Psychother. 2018 May;46(3):246-263. doi: 10.1024/1422-4917/a000546. Epub 2017 Sep 18.
8
Glutamate-modulating drugs as novel pharmacotherapeutic agents in the treatment of obsessive-compulsive disorder.谷氨酸调节药物作为治疗强迫症的新型药物治疗剂。
NeuroRx. 2006 Jan;3(1):69-81. doi: 10.1016/j.nurx.2005.12.006.
9
Glutamatergic dysfunction--newer targets for anti-obsessional drugs.谷氨酸能功能障碍——抗强迫药物的新靶点
Recent Pat CNS Drug Discov. 2007 Jan;2(1):47-55. doi: 10.2174/157488907779561727.
10
Current and up-and-coming pharmacotherapy for obsessive-compulsive disorder in adults.成人强迫症的当前和新兴药物治疗。
Expert Opin Pharmacother. 2018 Oct;19(14):1541-1550. doi: 10.1080/14656566.2018.1528230. Epub 2018 Oct 15.

引用本文的文献

1
Memantine augmentation of escitalopram in treatment of executive function among patients with obsessive-compulsive disorder (OCD): a double-blind placebo-controlled randomized clinical trial.美金刚增效艾司西酞普兰治疗强迫症患者执行功能的双盲安慰剂对照随机临床试验。
BMC Psychiatry. 2025 Jun 2;25(1):561. doi: 10.1186/s12888-025-06856-7.
2
Glutamatergic Medications for Obsessive-Compulsive and Related Disorders: A Systematic Review and Meta-Analysis.用于强迫症及相关障碍的谷氨酸能药物:一项系统评价与荟萃分析
JAMA Netw Open. 2025 Jan 2;8(1):e2452963. doi: 10.1001/jamanetworkopen.2024.52963.
3
A biophysical model for dopamine modulating working memory through reward system in obsessive-compulsive disorder.
一种用于解释多巴胺通过强迫症奖励系统调节工作记忆的生物物理模型。
Cogn Neurodyn. 2024 Aug;18(4):1895-1911. doi: 10.1007/s11571-023-09999-z. Epub 2023 Aug 25.
4
Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder.解锁裸盖菇素的治疗潜力:裸盖菇素疗法在重度抑郁症、强迫症和物质使用障碍中的作用概述
Front Psychiatry. 2024 Jun 11;15:1406888. doi: 10.3389/fpsyt.2024.1406888. eCollection 2024.
5
Clinical Effectiveness of N-Methyl-D-Aspartate (NMDA) Receptor Antagonists in Adult Obsessive-Compulsive Disorder (OCD) Treatment: A Systematic Review.N-甲基-D-天冬氨酸(NMDA)受体拮抗剂在成人强迫症(OCD)治疗中的临床疗效:一项系统评价。
Cureus. 2023 Apr 19;15(4):e37833. doi: 10.7759/cureus.37833. eCollection 2023 Apr.
6
Potential therapeutic mechanism of deep brain stimulation of the nucleus accumbens in obsessive-compulsive disorder.伏隔核深部脑刺激治疗强迫症的潜在机制
Front Cell Neurosci. 2023 Jan 4;16:1057887. doi: 10.3389/fncel.2022.1057887. eCollection 2022.
7
Virtual reality exposure and response prevention in the treatment of obsessive-compulsive disorder in patients with contamination subtype in comparison with in vivo exposure therapy: a randomized clinical controlled trial.虚拟现实暴露和反应预防治疗污染亚型强迫症患者与现场暴露疗法的比较:一项随机临床试验。
BMC Psychiatry. 2022 Nov 28;22(1):740. doi: 10.1186/s12888-022-04402-3.
8
Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial.盐酸美金刚联合舍曲林治疗强迫症患者的症状和执行功能:一项双盲安慰剂对照、随机临床试验。
BMC Psychiatry. 2022 Jan 12;22(1):34. doi: 10.1186/s12888-021-03642-z.
9
Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis.谷氨酸能药物作为成人中重度强迫症的辅助治疗:系统评价和荟萃分析。
BMC Pharmacol Toxicol. 2021 Nov 4;22(1):69. doi: 10.1186/s40360-021-00534-6.
10
Forgetting Unwanted Memories: Active Forgetting and Implications for the Development of Psychological Disorders.遗忘 unwanted Memories:主动遗忘及其对心理障碍发展的影响。 (注:原文中“unwanted Memories”这里的“unwanted”含义不太明确,可能是特定语境下的表述,正常翻译为“不需要的、多余的”等,结合这里大概意思就是“多余的记忆” )
J Pers Med. 2021 Mar 26;11(4):241. doi: 10.3390/jpm11040241.